Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Tongue Neoplasms 1Thymoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Endometrial Stromal 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Dermatofibrosarcoma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Bone Neoplasms 1Bone Diseases 1

Interventions

Carboplatin 6Paclitaxel 5Taxes 3Docetaxel 3Cisplatin 3Gemcitabine 2Erlotinib Hydrochloride 2Drug Therapy 2Bevacizumab 2talimogene laherparepvec 1saracatinib 1romidepsin 1rilotumumab 1ganitumab 1Zoledronic Acid 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Therapeutics 1Talc 1Surveys and Questionnaires 1Spectrum Analysis 1Sodium Chloride 1Pemetrexed 1Nivolumab 1Metformin 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Imatinib Mesylate 1Gefitinib 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pleural Effusion, Malignant × saracatinib × Clear all
NCT00528645 2017-12-07

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
23 enrolled 7 charts
Thoracic

Pleural Effusion, Malignant, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡